Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation

Abstract

Transplantation of HLA-mismatched stem cells may allow determination of chimerism status of single cells by differential expression of HLA molecules. Monoclonal antibodies against HLA antigens can be used to determine the HLA type of sub-populations by standard flow cytometry. Blood samples from 23 patients transplanted from HLA-mismatched family donors were monitored using HLA-specific antibodies. Suitable antibodies could be found for all donor recipient pairs by using differences in HLA Bw4 and Bw6 groups or other serological antigens. Pretransplant controls of donor and recipient were used to correct for variable fluorescence intensities of the antibodies and sub-populations. Owing to the high sensitivity, cell populations with a minimum frequency of 0.1% were detectable. Flow-cytometric analysis was confirmed by chimerism analysis of immunomagnetically isolated T cells by standard PCR technique. In addition to chimerism evaluation, HLA antibodies improved the detection of leukemic cells after transplantation with aberrant phenotype. In conclusion, flow cytometry using antibodies against HLA antigens is an interesting tool for determination of chimerism and minimal residual disease after HLA-mismatched transplantation. Information about the chimerism status is given on a single-cell level and allows fast and convenient analysis of sub-populations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Lang P, Schumm M, Greil J, Bader P, Klingebiel T, Muller I et al. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin Padiatr 2005; 217: 334–338.

    Article  CAS  Google Scholar 

  2. Handgretinger R, Klingebiel T, Lang P, Schumm M, Neu S, Geiselhart A et al. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001; 27: 777–783.

    Article  CAS  Google Scholar 

  3. Lang P, Greil J, Bader P, Handgretinger R, Klingebiel T, Schumm M et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 2004; 33: 281–287.

    Article  Google Scholar 

  4. Kurtzberg J, Graham M, Casey J, Olson J, Stevens CE, Rubinstein P . The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 1994; 20: 275–283.

    CAS  PubMed  Google Scholar 

  5. Lambertengh DG, Soligo D, Della VA, Bertolini F, Poli F, Romitti L et al. Unrelated mismatched cord blood transplantation in an adult with secondary AML. Bone Marrow Transplant 1996; 18: 469–472.

    Google Scholar 

  6. Jaing TH, Hung IJ, Yang CP, Chen SH, Sun CF, Chow R . Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biol Blood Marrow Transplant 2005; 11: 349–353.

    Article  Google Scholar 

  7. Quesenberry PJ, Zhong S, Wang H, Stewart M . Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice. Blood 2001; 97: 557–564.

    Article  CAS  Google Scholar 

  8. Truitt RL, Atasoylu AA . Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood 1991; 77: 2515–2523.

    CAS  PubMed  Google Scholar 

  9. Ceredig R, Schreyer M . Immunohistochemical localization of host and donor-derived cells in the regenerating thymus of radiation bone marrow chimeras. Thymus 1984; 6: 15–26.

    CAS  PubMed  Google Scholar 

  10. Bachar-Lustig E, Li HW, Gur H, Krauthgamer R, Marcus H, Reisner Y . Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(−) bone marrow progenitor cells: synergism with non-alloreactive (host × donor)F(1) T cells. Blood 1999; 94: 3212–3221.

    CAS  PubMed  Google Scholar 

  11. Fuehrer M, Gerusel-Bleck M, Konstantopoulos N, der-Goetze C, Walther JU . FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children. Int J Mol Med 2005; 15: 291–297.

    CAS  PubMed  Google Scholar 

  12. Turkiewicz D, Gorczynska E, Toporski J, Kalwak K, Rybka B, Noworolska D et al. Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes. Leuk Res 2003; 27: 993–998.

    Article  CAS  Google Scholar 

  13. Lapointe C, Forest L, Lussier P, Busque L, Lagace F, Perreault C et al. Sequential analysis of early hematopoietic reconstitution following allogeneic bone marrow transplantation with fluorescence in situ hybridization (FISH). Bone Marrow Transplant 1996; 17: 1143–1148.

    CAS  PubMed  Google Scholar 

  14. Palka G, Stuppia L, Di BP, Morizio E, Peila R, Franchi PG et al. FISH detection of mixed chimerism in 33 patients submitted to bone marrow transplantation. Bone Marrow Transplant 1996; 17: 231–236.

    CAS  PubMed  Google Scholar 

  15. Zeng F, Chen M, Katsumata M, Huang W, Gong Z, Hu W et al. Identification and characterization of engrafted human cells in human/goat xenogeneic transplantation chimerism. DNA Cell Biol 2005; 24: 403–409.

    Article  CAS  Google Scholar 

  16. Fehse B, Chukhlovin A, Kuhlcke K, Marinetz O, Vorwig O, Renges H et al. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. J Hematother Stem Cell Res 2001; 10: 419–425.

    Article  CAS  Google Scholar 

  17. Bader P, Holle W, Klingebiel T, Handgretinger R, Niethammer D, Beck J . Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT. Anticancer Res 1996; 16: 1759–1763.

    CAS  PubMed  Google Scholar 

  18. Kreyenberg H, Holle W, Mohrle S, Niethammer D, Bader P . Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience. Leukemia 2003; 17: 237–240.

    Article  CAS  Google Scholar 

  19. Bader P, Niemeyer C, Willasch A, Kreyenberg H, Strahm B, Kremens B et al. Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy. Br J Haematol 2005; 128: 649–658.

    Article  Google Scholar 

  20. Cotteret S, Belloc F, Boiron JM, Bilhou-Nabera C, Dumain P, Boyer C et al. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation. Cytometry 1998; 34: 216–222.

    Article  CAS  Google Scholar 

  21. Matthes-Martin S, Lion T, Haas OA, Frommlet F, Daxberger H, Konig M et al. Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection. Leukemia 2003; 17: 1934–1942.

    Article  CAS  Google Scholar 

  22. Kogler G, Wolf HH, Heyll A, Arkesteijn G, Wernet P . Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells. Bone Marrow Transplant 1995; 15: 41–48.

    CAS  PubMed  Google Scholar 

  23. Gerritsen WR, Jagiello CA, Bourhis JH . Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens. Bone Marrow Transplant 1994; 13: 441–447.

    CAS  PubMed  Google Scholar 

  24. Handgretinger R, Schumm M, Lang P, Greil J, Reiter A, Bader P et al. Transplantation of megadoses of purified haploidentical stem cells. Ann N Y Acad Sci 1999; 872: 351–361.

    Article  CAS  Google Scholar 

  25. Schwinger W, Urban C, Lackner H, Kerbl R, Benesch M, Dornbusch HJ et al. Unrelated peripheral blood stem cell transplantation with ‘megadoses’ of purified CD34+ cells in three children with refractory severe aplastic anemia. Bone Marrow Transplant 2000; 25: 513–517.

    Article  CAS  Google Scholar 

  26. Reisner Y, Martelli MF . Tolerance induction by ‘megadose’ transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor. Curr Opin Immunol 2000; 12: 536–541.

    Article  CAS  Google Scholar 

  27. Bethge WA, Haegele M, Faul C, Lang P, Schumm M, Bornhauser M et al. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. Exp Hematol 2006; 34: 1746–1752.

    Article  CAS  Google Scholar 

  28. Bader P, Hancock J, Kreyenberg H, Goulden NJ, Niethammer D, Oakhill A et al. Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia 2002; 16: 1668–1672.

    Article  CAS  Google Scholar 

  29. Campana D, Coustan-Smith E . Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 1999; 38: 139–152.

    Article  CAS  Google Scholar 

  30. Kerst G, Kreyenberg H, Roth C, Well C, Dietz K, Coustan-Smith E et al. Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR. Br J Haematol 2005; 128: 774–782.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Olga Bartuli, Christiane Braun, Gabriele Hochwelker, Ulrike Junker, Stephanie Katz, Susanne Schneider and Anja Wolf for excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Schumm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schumm, M., Feuchtinger, T., Pfeiffer, M. et al. Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation. Bone Marrow Transplant 39, 767–773 (2007). https://doi.org/10.1038/sj.bmt.1705676

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705676

Keywords

This article is cited by

Search

Quick links